Janka-Schaub G - Search Results

1

Late manifestation of diabetes insipidus in "pure" cutaneous Langerhans cell histiocytosis.

Hoeger PH, Janka-Schaub G, Mensing H. Hoeger PH, et al. Eur J Pediatr. 1997 Jul;156(7):524-7. doi: 10.1007/s004310050653. Eur J Pediatr. 1997. PMID: 9243232

2

Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis.

Minkov M, Pötschger U, Thacker N, Astigarraga I, Braier J, Donadieu J, Henter JI, Lehrnbecher T, Rodriguez-Galindo C, Sieni E, Nanduri V, van den Bos C, Abla O; LCH Study Group of the Histiocyte Society. Minkov M, et al. J Pediatr. 2021 Oct;237:65-70.e3. doi: 10.1016/j.jpeds.2021.06.016. Epub 2021 Jun 17. J Pediatr. 2021. PMID: 34146548 Free article.

3

Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood--follow up after 9 years. Coall Study Group.

Janka-Schaub GE, Harms D, Goebel U, Graubner U, Gutjahr P, Haas RJ, Juergens H, Spaar HJ, Winkler K. Janka-Schaub GE, et al. Eur J Pediatr. 1996 Aug;155(8):640-8. doi: 10.1007/BF01957144. Eur J Pediatr. 1996. PMID: 8839716 Clinical Trial.

4

Risk factors for diabetes insipidus in langerhans cell histiocytosis.

Grois N, Pötschger U, Prosch H, Minkov M, Arico M, Braier J, Henter JI, Janka-Schaub G, Ladisch S, Ritter J, Steiner M, Unger E, Gadner H; DALHX- and LCH I and II Study Committee. Grois N, et al. Pediatr Blood Cancer. 2006 Feb;46(2):228-33. doi: 10.1002/pbc.20425. Pediatr Blood Cancer. 2006. PMID: 16047354

5

Langerhans cell histiocytosis in neonates.

Minkov M, Prosch H, Steiner M, Grois N, Pötschger U, Kaatsch P, Janka-Schaub G, Gadner H. Minkov M, et al. Pediatr Blood Cancer. 2005 Nov;45(6):802-7. doi: 10.1002/pbc.20362. Pediatr Blood Cancer. 2005. PMID: 15770639

6

Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.

Haupt R, Nanduri V, Calevo MG, Bernstrand C, Braier JL, Broadbent V, Rey G, McClain KL, Janka-Schaub G, Egeler RM. Haupt R, et al. Pediatr Blood Cancer. 2004 May;42(5):438-44. doi: 10.1002/pbc.20021. Pediatr Blood Cancer. 2004. PMID: 15049016

7

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.

Gadner H, Minkov M, Grois N, Pötschger U, Thiem E, Aricò M, Astigarraga I, Braier J, Donadieu J, Henter JI, Janka-Schaub G, McClain KL, Weitzman S, Windebank K, Ladisch S; Histiocyte Society. Gadner H, et al. Among authors: janka schaub g. Blood. 2013 Jun 20;121(25):5006-14. doi: 10.1182/blood-2012-09-455774. Epub 2013 Apr 15. Blood. 2013. PMID: 23589673 Free article. Clinical Trial.

8

Natural killer deficiency: a minor or major factor in the manifestation of hemophagocytic lymphohistiocytosis?

Schneider EM, Lorenz I, Walther P, Janka-Schaub GE. Schneider EM, et al. J Pediatr Hematol Oncol. 2003 Sep;25(9):680-3. doi: 10.1097/00043426-200309000-00002. J Pediatr Hematol Oncol. 2003. PMID: 12972801 Review. No abstract available.

9

Treatment of chronic neutropenia of childhood responsive to cyclosporin A in vitro and in vivo.

Janka-Schaub GE, Raghavachar A, Rister M, Belohradsky BM. Janka-Schaub GE, et al. Int J Hematol. 1992 Apr;55(2):157-63. Int J Hematol. 1992. PMID: 1511165

10

Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92.

Harms DO, Göbel U, Spaar HJ, Graubner UB, Jorch N, Gutjahr P, Janka-Schaub GE; COALL Study Group. Harms DO, et al. Blood. 2003 Oct 15;102(8):2736-40. doi: 10.1182/blood-2002-08-2372. Epub 2003 Jul 3. Blood. 2003. PMID: 12843002 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page